Q&A: How an ovarian cancer biopsy test can make a lasting difference to women’s health

Oriana Papin-Zoghbi, CEO and co-founder of AOA spoke to Med-Tech Innovation News to discuss its offering, which includes an early-stage ovarian cancer biopsy test.

Show CommentsClose Comments

Leave a comment

%d bloggers like this: